Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Medifast (MED) Shares Repurchased (2018 - 2023)

Medifast's Shares Repurchased history spans 9 years, with the latest figure at $3.6 million for Q1 2023.

For Q1 2023, Shares Repurchased fell 63.98% year-over-year to $3.6 million; the TTM value through Dec 2023 reached $3.6 million, down 97.15%, while the annual FY2023 figure was $3.6 million, 97.15% down from the prior year.
Shares Repurchased reached $3.6 million in Q1 2023 per MED's latest filing, down from $6.4 million in the prior quarter.
In the past five years, Shares Repurchased ranged from a high of $110.0 million in Q2 2022 to a low of $3.6 million in Q1 2023.
Average Shares Repurchased over 4 years is $23.2 million, with a median of $10.0 million recorded in 2022.
Peak YoY movement for Shares Repurchased: soared 799.82% in 2022, then plummeted 63.98% in 2023.
A 4-year view of Shares Repurchased shows it stood at $23.1 million in 2019, then tumbled by 56.74% to $10.0 million in 2021, then crashed by 36.02% to $6.4 million in 2022, then plummeted by 43.69% to $3.6 million in 2023.
Per Business Quant, the three most recent readings for MED's Shares Repurchased are $3.6 million (Q1 2023), $6.4 million (Q4 2022), and $110.0 million (Q2 2022).